Skip to main content
Brandon Busbee, MD, Ophthalmology, Nashville, TN, Ascension Saint Thomas

BrandonGreerBusbeeMD

Ophthalmology Nashville, TN

Retinal Disease

Retina surgery and medicine / Partner Tenneessee Retina

Dr. Busbee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Busbee's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1999 - 2002
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1998

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2004 - 2024
  • MA State Medical License
    MA State Medical License 2002 - 2004
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration  
    Srinivas R Sadda, Brandon Busbee, Emily Y Chew, Neil M Bressler, JAMA

Press Mentions

  • Adverum Biotechnologies Presents Long-Term Data Through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-Experienced Wet AMD Patients at ARVO 2021
    Adverum Biotechnologies Presents Long-Term Data Through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-Experienced Wet AMD Patients at ARVO 2021May 1st, 2021

Professional Memberships

Hospital Affiliations